Paul P. Tamburini

C3 glomerulopathy: consensus report

Matthew C. Pickering, Vivette D. D’Agati, Carla Nester et al. · Kidney International · 2013 · 641 citations · Full text

Medicine, Nephrology, Pathology +17

Genetic Variants in C5 and Poor Response to Eculizumab

Jun‐ichi Nishimura, Masaki Yamamoto, Shin Hayashi et al. · New England Journal of Medicine · 2014 · 410 citations · Full text

Life Sciences, Genetics, Hematology +17

Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action

Douglas Sheridan, Zhao-Xue Yu, Yuchun Zhang et al. · PLoS ONE · 2018 · 251 citations · Full text

Pharmacy, Immunology, Pharmacology +17

Cytochrome <i>P</i>-450 induction by clofibrate. Purification and properties of a hepatic cytochrome <i>P</i>-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid)

G. Gordon Gibson, Terry C. Orton, Paul P. Tamburini · Biochemical Journal · 1982 · 222 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Multiple forms of hepatic cytochrome P-450. Purification, characterisation and comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome P-450

Paul P. Tamburini, Hilary A. Masson, Satinder Bains et al. · European Journal of Biochemistry · 1984 · 207 citations · Full text

Medicine, Biochemistry, Pharmacology +17